Perspectives on Integrative Medicine

Original Article

A Survey of the Clinical Practice of Korean Medicine for Smoking Cessation in Public Health Centers: A Web-Based Survey of Public Health Doctors of Korean Medicine: Gyoungeun Park, Jeong-Hyun Moon, Eun-Jung Kim, Byung-Kwan Seo, Yong-Hyeon Baek, Won-Suk Sung; Perspect Integr Med. 2024;3(1):45-50. Published online February 22, 2024; DOI: https://doi.org/10.56986/pim.2024.02.006

500 View
9 Download

Graphical Abstract Abstract PDF Supplementary Material: Background
In South Korea, public health centers provide smoking cessation (SC) treatments including behavioral therapy and nicotine replacement treatment. Also, public health doctors of Korean medicine (PHDKMs) are providing Korean Medicine (KM) treatments. Several studies have reported the clinical usefulness of KM treatment, but in this study, the opinion of PHDKMs was explored to examine the current KM treatments for SC.
Methods
A web-based survey (Moaform) of the treatment for SC by PHDKMs consisted of 5 main sections including clinical practice status, SC participants, KM treatments for SC, progress and prognosis, and perception of KM. The survey was emailed twice to 621 PHDKMs on April 6 to 20, 2022. The frequencies and percentages of each question were calculated.
Results
There were 28 PHDKMs who participated in the survey. Among them, over 90% of PHDKMs had treated ≤ 10 SC participants, and about 10% of PHDKMs had treated 11-20 participants. The abstinence rate was 56.8% with an average 63.2% level of satisfaction in the treatment. Typically used, and recognized as important KM treatments, were auricular acupuncture, acupuncture, education, and herbal medicine. While auricular acupuncture and education were perceived as convenient KM treatment, PHDKMs thought that SC could not be achieved with KM treatment alone and needed be combined with other treatments.
Conclusion
This survey showed the effectiveness of KM treatments with withdrawal symptoms, and treatment satisfaction of SC participants. Respondents also thought that KM treatment combined with other treatments is more effective than KM monotherapy. Based on this small study, further research would be needed.

Protocol

Effectiveness and Safety of Duantengyimu-tang for Rheumatoid Arthritis: A Protocol for a Systematic Review and Meta-Analysis: Gyoungeun Park, Jeong-Hyun Moon, Eun-Jung Kim, Won-Suk Sung; Perspect Integr Med. 2023;2(2):134-137. Published online June 23, 2023; DOI: https://doi.org/10.56986/pim.2023.06.009

703 View
10 Download

Abstract PDF: Background
Per-oral pharmacological medication is a representative treatment for rheumatoid arthritis (RA), and has improved over several guidelines. However, limitations of long-term use of these medications including adverse events, led to the introduction and utilization of complementary and alternative treatments for RA. Several herbal medicine decoctions have been reported to be effective and safe; a recent study introduced Duantengyimu-tang (DTYMT). Regardless of the pharmacological effects of the DTYMT components, there are concerns about its safety. Therefore, this systematic review (SR) will focus on the effectiveness and safety of DTYMT treatment for RA.
Methods
Searches for randomized controlled trials using DTYMT treatment for RA will be performed using multiple electronic databases, manual searches, and emails (if necessary). A summary will be written using data on outcome measurements of the study participants, interventions, adverse events, and risk of bias in the studies. The primary outcomes will be disease activity scores including effective rate, tender joints, swollen joints, and morning stiffness. The secondary outcomes will include adverse events and blood tests for RA (erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factors). This SR will use Review Manager software to perform a meta-analysis, the Cochrane Collaboration “risk of bias” tool, and determine the quality of evidence using the Grades of Recommendation, Assessment, Development, and Evaluation method.
Results
This SR will investigate the clinical effectiveness and safety of DTYMT treatment in patients with RA.
Conclusion
This SR aims to be informative for patients and clinicians in clinical practice, researchers, and policymakers in managing RA.

Original Article

Current Status of Korean Medicine Treatment for Post-acute COVID-19 Syndrome: A Survey of Korean Medicine Doctors: Doori Kim, Seo-Hyun Park, Won-Suk Sung, Eun-Jung Kim; Perspect Integr Med. 2022;1(1):34-44. Published online September 22, 2022; DOI: https://doi.org/10.56986/pim.2022.09.006

1,427 View
40 Download

Abstract PDF Supplementary Material: Background
The applicability of Korean medicine (KM) treatments for post-acute COVID-19 syndrome were investigated.
Methods
A cross-sectional, web-based survey of Korean medical doctors (KMDs) was conducted in June 2022. The 25-item questionnaire comprised of five parts: basic characteristics, prescribed post-COVID-19 KM treatments, treatment effect in patients with post-acute COVID-19 syndrome, patient satisfaction, and awareness and utilization of the relevant KM Clinical Practice Guideline by the KMDs.
Results
In total, 1,063 completed questionnaires were collected, and 822 were analyzed. The most common symptoms in patients with post-acute COVID-19 syndrome treated by KMDs was weakness and fatigue (84.3%). Herbal decoctions (39.2%) and herbal powder (not covered by medical insurance; 25.8%) were primarily used. Among the KMDs, 95% (n = 781) responded that KM treatments, particularly herbal decoctions (82.6%) and herbal powder (not covered by medical insurance; 46.8%), were effective. Overall, 92.6% (n = 761) of KMD participants answered that the patients were satisfied with KM treatments, mostly due to symptomatic improvement (60.8%). The primary reason for dissatisfaction was the burden of cost for patients (78.4%). The main reasons for low uptake of KM services by patients with post-acute COVID-19 syndrome were lack of publicity and administrative issues such as no health insurance coverage.
Conclusion
KM is highly applicable for post-acute COVID-19 syndrome. Health policies supporting the use of KM for post-acute COVID-19 syndrome are recommended.

First
Prev
Page of 1
Next
Last

Search